UK markets closed

ImmuPharma plc (IMM.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1.7750+0.0025 (+0.14%)
At close: 04:13PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
118.35
126.667
Operating expenses
Research development
2,022
2,022
2,023
3,650
2,373
Selling general and administrative
1,020
1,020
846.571
1,011
1,765
Total operating expenses
3,063
3,063
3,029
5,278
5,716
Operating income or loss
-3,063
-3,063
-3,029
-5,160
-5,589
Interest expense
1.986
1.986
2.036
124.063
230.828
Income before tax
-3,419
-3,419
-4,456
-8,941
-7,246
Income tax expense
-497.102
-497.102
-648.902
-766.814
-386.248
Income from continuing operations
-2,922
-2,922
-3,807
-8,174
-6,860
Net income
-2,922
-2,922
-3,807
-8,174
-6,860
Net income available to common shareholders
-2,922
-2,922
-3,807
-8,174
-6,860
Basic EPS
-0.01
-0.01
-0.01
-0.03
-0.03
Diluted EPS
-0.01
-0.01
-0.01
-0.03
-0.03
Basic average shares
327,122
362,005
302,913
251,164
200,176
Diluted average shares
327,122
362,005
302,913
251,164
200,176